US approves Ascendis Pharma’s therapy for hormone disorders
Ascendis Pharma said the US Food and Drug Administration approved its therapy to treat adult patients with a hormone disorder. This sent the drugmaker’s shares up more than 10%.
BELIEBTE BEITRÄGE
Poland prepares for peaking floods
September 20, 2024
Italy evacuates thousands as Boris hits the north
September 20, 2024
China and the US race to tame nuclear fusion for clean energy
September 20, 2024
LIVEÜBERTRAGUNG